Sonnet BioTherapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

Stockholders’ Equity (Details Narrative) - USD ($)			1 Months Ended	6 Months Ended	9 Months Ended
Stockholders’ Equity (Details Narrative) - USD ($)	Feb. 05, 2021	Apr. 02, 2020	Aug. 31, 2019	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued			757,933
Shars issued to acquire assets					757,933
Proceeds from exercise of warrants					$ 2
Series B Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued					2,242,339
Warrants exercised					23,863
Proceeds from exercise of warrants					$ 2
Net share settled					2,242,427
Chanticleer Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price					$ 0.01
Number of shares issued					185,422
Number of purchase warrant					186,161
Investors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, shares		1,699,232
Proceeds from issuance of common stock		$ 15,000,000
Investors [Member] \| Series A Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant issued		3,300,066
Warrant exercise price		$ 5.3976
Investors [Member] \| Series B Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant issued		2,247,726
Warrant exercise price		$ 0.0001
Advisor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued		453,128
Legacy Chanticleer Shareholders [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant issued				206,371
Shares issued for merger				547,639
Warrant, weighted average exercise price							$ 26.60
Legacy Chanticleer Shareholders [Member] \| Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price							0.01
Legacy Chanticleer Shareholders [Member] \| Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant exercise price							$ 1,820
Promissory Notes [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, shares				186,075
Proceeds from issuance of common stock				$ 4,100,000
Warrant issued				93,038
Warrant exercise price				$ 29.32
Debt conversion of common stock shares				8,526
Debt conversion of common stock, value				$ 200,000
At The Market Sales Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, shares					7,454,238
Gross proceeds from sale agreement					$ 15,900,000
Proceeds from issuance of common stock	$ 15,875,000				$ 15,300,000
Shares issued upon vesting					127,880